Aptose Picks Up Hanmi’s MKI To Buoy Hematological Cancer Pipeline

$420m Deal Follows Positive Data

leukemia
HM43239 Shows Significant Genotype-Agnostic Anti-Leukemic Activity In Phase I/II • Source: Alamy

More from Deals

More from Business